Essity will publish its Q4 and full-year 2025 report on Jan. 22, 2026 at approximately 07:00 CET and will host a live webcast and teleconference with CEO Ulrika Kolsrud and CFO Fredrik Rystedt at 09:00 CET (with Q&A); access and call-in details are provided. The results and any accompanying FY25 guidance will be the primary near-term catalyst for the Nasdaq Stockholm-listed hygiene and health group, which reported about SEK 146bn (EUR 13bn) in net sales in 2024 and employs roughly 36,000 people.
Essity will publish its Q4 and full-year 2025 report on 22 January 2026 at approximately 07:00 CET and host a live webcast and teleconference at 09:00 CET featuring President and CEO Ulrika Kolsrud and EVP/CFO Fredrik Rystedt; access and dial-in details are provided and the presentation includes a Q&A opportunity. The company reported approximately SEK 146bn (EUR 13bn) in net sales for 2024 and employs about 36,000 people, with operations and sales conducted in roughly 150 countries under global brands such as TENA and Tork and several regional consumer and medical brands. The scheduled results release and any accompanying FY25 guidance will be the primary near-term catalyst for the Nasdaq Stockholm-listed group, with management commentary during the webcast key to interpreting revenue drivers, margin trends and regional performance. Provided sentiment indicators are neutral (sentiment_score 0.0) and market impact is low (0.05), but event-driven volatility is possible around the release so investors should treat the report as a discrete execution and guidance event rather than routine disclosure.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
